Published in J Hypertens on August 01, 2007
Central Pressure Appraisal: Clinical Validation of a Subject-Specific Mathematical Model. PLoS One (2016) 1.44
Orthostatic hypertension-a new haemodynamic cardiovascular risk factor. Nat Rev Nephrol (2013) 0.90
Cystathionine-γ lyase-derived hydrogen sulfide mediates the cardiovascular protective effects of moxonidine in diabetic rats. Eur J Pharmacol (2016) 0.77
Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med (2005) 7.66
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J (2006) 5.93
Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation (2006) 3.82
Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J (2003) 3.73
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet (2013) 2.83
Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab (2004) 2.56
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr (2012) 2.41
Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension (2012) 2.31
Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension (2005) 2.03
Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation (2015) 1.95
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med (2005) 1.83
Comparison of echocardiographic features of noncompaction of the left ventricle in adults versus idiopathic dilated cardiomyopathy in adults. Am J Cardiol (2004) 1.78
What is the best approach for the assessment of left atrial size? Comparison of various unidimensional and two-dimensional parameters with three-dimensional echocardiographically determined left atrial volume. J Am Soc Echocardiogr (2006) 1.76
Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension (2013) 1.76
Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care (2013) 1.55
Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography. Pacing Clin Electrophysiol (2011) 1.54
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab (2009) 1.53
Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER Project. J Hypertens (2003) 1.52
Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ. Mol Cell (2011) 1.52
KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension (2011) 1.51
Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells (2009) 1.50
Concurrent primary aldosteronism and subclinical cortisol hypersecretion: a prospective study. J Hypertens (2011) 1.50
Tissue Doppler echocardiography: principles and applications. Indian Heart J (2002) 1.47
Assessment of cardiac autonomic modulation during adolescent obesity. Obes Res (2003) 1.45
Reversal of left ventricular remodeling by pericardial tamponade. J Card Fail (2005) 1.45
Anti-hypertensive drugs and left ventricular hypertrophy: a clinical update. Intern Emerg Med (2010) 1.43
[Assessment of cardiovascular risk in hypertensive patients: comparison among scores]. Ital Heart J Suppl (2004) 1.40
[Hypertensive emergency and urgency: clinical update]. G Ital Cardiol (Rome) (2010) 1.40
[Hypertensive heart disease: diagnostic and therapeutic guidelines]. G Ital Cardiol (Rome) (2008) 1.39
Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab (2005) 1.36
A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression. Am Heart J (2002) 1.33
EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging (2012) 1.33
Postoperative cardiac tamponade in the modern surgical era. Ann Thorac Surg (2002) 1.30
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension (2002) 1.23
Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol (2012) 1.20
Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab (2005) 1.19
Prognostic relevance of masked hypertension in subjects with prehypertension. Am J Hypertens (2008) 1.17
Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging (2013) 1.16
Echocardiographic indexes for the non-invasive evaluation of pulmonary hemodynamics. J Am Soc Echocardiogr (2010) 1.15
Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab (2013) 1.15
Use of pulse wave and color flow Doppler echocardiography in mouse models of human disease. J Am Soc Echocardiogr (2002) 1.14
Quantitation of right ventricular volumes and ejection fraction by three-dimensional echocardiography in patients: comparison with magnetic resonance imaging and radionuclide ventriculography. Echocardiography (2006) 1.14
Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab (2008) 1.12
Percutaneous mitral valve repair: a feasibility study in an ovine model of acute ischemic mitral regurgitation. Catheter Cardiovasc Interv (2003) 1.10
Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse. Clin Sci (Lond) (2003) 1.09
Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. Proc Natl Acad Sci U S A (2004) 1.09
Essential role of the p110beta subunit of phosphoinositide 3-OH kinase in male fertility. Mol Biol Cell (2010) 1.07
Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data. J Neurol Sci (2002) 1.07
Orthostatic hypotension: evaluation and treatment. Cardiovasc Hematol Disord Drug Targets (2007) 1.07
a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III. J Clin Endocrinol Metab (2013) 1.05
Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension (2010) 1.05
Left ventricular hypertrophy in patients with autonomic failure. Am J Hypertens (2006) 1.05
The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function. Antivir Ther (2005) 1.03
Hypertension and cerebrovascular damage. Atherosclerosis (2008) 1.03
Relation between high-density lipoprotein cholesterol and peripheral vasomotor function. Am J Cardiol (2003) 1.01
LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms. Atherosclerosis (2009) 1.01
Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms). Hypertension (2011) 1.01
Recent role of imaging in the diagnosis of pericardial disease. Curr Cardiol Rep (2002) 0.99
Hypertension and cognitive function. Clin Exp Hypertens (2008) 0.99
Twice upon a time: PI3K's secret double life exposed. Trends Biochem Sci (2009) 0.98
Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis. Hypertension (2012) 0.97
Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study. Heart (2006) 0.97
Pre-operative left atrial mechanical function predicts risk of atrial fibrillation following cardiac surgery. JACC Cardiovasc Imaging (2011) 0.96
Similarities and differences in early retinal phenotypes in hypertension and diabetes. J Hypertens (2011) 0.96
Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab (2006) 0.95
Prolonged QT interval and reduced heart rate variability in patients with uncomplicated essential hypertension. Hypertens Res (2008) 0.95
Adiponectin and insulin sensitivity in primary aldosteronism. Am J Hypertens (2007) 0.94
Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro. Hypertension (2010) 0.94
Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree. J Clin Endocrinol Metab (2002) 0.94
Antihypertensive drugs and the sympathetic nervous system. J Cardiovasc Pharmacol (2007) 0.94
Arterial hypertension: a cause of cognitive impairment and of vascular dementia. Clin Exp Hypertens (2004) 0.93
Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism. Clin Chem (2007) 0.93